Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

LC-MS/MS System

By Drug Discovery Trends Editor | March 10, 2009

Thermo Fisher Scientific announced that the Thermo Scientific TSQ Vantage will make its debut at Pittcon 2009.

The TSQ Vantage offers up to 10 times the signal-to-noise ratio when compared to the Thermo Scientific TSQ Quantum series and far exceeds any other triple quadrupole instrument in the field, according to Thermo Fisher Scientific. The instrument’s exceptional performance is due to major technical innovations in ionization efficiency and ion transmission, according to the company.

The new S-Lens ion optics system in the TSQ Vantage employs novel electrostatic field technology to capture virtually every ion and efficiently transfer it into the Thermo Scientific HyperQuad quadrupole mass analyzer. The S-Lens design eliminates mass discrimination and lowers the gas load on the expensive turbo-molecular pumps. This innovation keeps the ion optical path cleaner, for a longer period of time, while maintaining sensitivity.

To maximize the workflow capabilities of the advanced LC-MS/MS technologies, the company is releasing Thermo Scientific Transcend, a sample extraction system for the analysis of complex matrices on the mass spectrometer. The Transcend system doubles sample analysis while reducing sample preparation time and increasing detection limits. This advanced online sample extraction system, coupled with highly sensitive MS/MS on the TSQ Vantage, provides an end-to-end workflow solution for analysis of drug and other organic molecules.

Visit Thermo Scientific at Pittcon 2009 at Booth #1432.

www.thermofisher.com


Filed Under: Drug Discovery

 

Related Articles Read More >

Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE